A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease

No abstract is available for this paper.

• Publication year

  1994

• Venue

  The New England Journal of Medicine

• Publication date

  1994-08-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199408253310802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Detailed angiographic analysis of high-speed mechanical rotational atherectomy in human coronary arteries.

  1993cited by this paper
• A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery.

  1993cited by this paper
• Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy.

  1993cited by this paper
• A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease

  1993cited by this paper
• Restenosis After Placement of Palmaz‐Schatz Stents in Native Coronary Arteries: Initial Results of a Multicenter Experience

  1992cited by this paper
• Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry.

  1992cited by this paper
• Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosis☆

  1991cited by this paper
• Effect of intracoronary stenting on intimal dissection after balloon angioplasty: results of quantitative and qualitative coronary analysis.

  1991cited by this paper
• Clinical Experience With the Palmaz‐Schatz Coronary Stent: Initial Results of a Multicenter Study

  1991cited by this paper
• A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group.

  1990cited by this paper
• Randomised trial of fish oil for prevention of restenosis after coronary angioplasty.

  1989cited by this paper
• "Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders and melters"--the future treatment of atherosclerotic coronary artery disease? A clinical-morphologic assessment.

  1989cited by this paper
• Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty.

  1989cited by this paper
• Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.

  1988cited by this paper
• Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients.

  1988cited by this paper
• Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids.

  1988cited by this paper
• Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method.

  1987cited by this paper
• Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience.

  1987cited by this paper
• Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty.

  1986cited by this paper
• Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty.

  1985cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

  1984cited by this paper
• Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.

  1984cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper

• A risk prediction nomogram for in-stent restenosis in patients with coronary heart disease: first exploratory analysis based on the substrate materials of drug-eluting stents

  2026cites this paper
• Beta-Blockers in Patients with Myocardial Infarction and No Heart Failure: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

  2026cites this paper
• Next-Generation Drug Delivery Systems and Drugs for Vascular Intervention

  2026cites this paper
• Drug-Coated Balloons in Coronary Bifurcation Disease: A State-of-the-Art Review.

  2026cites this paper
• Antiplatelet treatment after drug-coated balloon treatment: review of the current evidence and future perspectives.

  2026cites this paper
• Small‐Diameter Stents in Cardiovascular Applications

  2025cites this paper
• Coronary Intervention: History and Current Status

  2025cites this paper
• Safety and Efficacy of Different Stent Strategies in Percutaneous Coronary Intervention

  2025cites this paper
• From better stents to better healing: Interpreting the TRANSEVER registry through the lens of vascular recovery.

  2025cites this paper
• Heparin Coating Decreases the Thrombotic Signature of Flow Diverter Stents

  2025cites this paper
• Coronary Intervention in Kawasaki Disease

  2025cites this paper
• Evolution of Coronary Stents: From Birth to Future Trends

  2025cites this paper
• Room-Temperature Superplasticity in a Biodegradable Zn-0.1Mg Alloy

  2025cites this paper
• Nitinol Stent Placement in a Stenosed Artery: A Highly Nonlinear Application Scenario for Two Novel Finite-Element Models

  2025cites this paper
• Coronary Stents: All Those Trials

  2025cites this paper
• Prospective randomized single-blind multicenter study to assess the safety and effectiveness of the SELUTION SLR 014 drug eluting balloon in the treatment of subjects with in-stent restenosis: rationale and design.

  2025cites this paper
• Stents coronaires actifs et DAPT : données de la littérature, limites méthodologiques et implications suggérant une prise de décision individuelle optimale

  2025cites this paper
• Late Effect of an Embolized Coronary Stent in the Lower Extremities

  2025cites this paper
• The impact of drug eluting stents on the co-release of interleukin-6 in patients with stable angina

  2024cites this paper
• Current Challenges in Coronary Bifurcation Interventions

  2024cites this paper
• Revolutionizing Cardiovascular Frontiers: A Dive Into Cutting-Edge Innovations in Coronary Stent Technology.

  2024cites this paper
• Evolution of Therapeutic Interventions in Ischemic Heart Disease: A Global Perspective

  2024cites this paper
• 3D printed polymeric stent design: Mechanical testing and computational modeling

  2024cites this paper
• In-Stent Re-Endothelialization Strategies: Cells, Extracellular Matrix, and Extracellular Vesicles

  2024cites this paper
• Streamlining same-day discharge for percutaneous coronary intervention: A single-center experience

  2024cites this paper
• Provinols™, a Polyphenolic Extract of Red Wine, Inhibits In-Stent Neointimal Growth in Cholesterol-Fed Rabbit

  2024cites this paper
• Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial.

  2024cites this paper
• Resistant Drug-Eluting Stent Restenosis and Resurrection of Intracoronary Brachytherapy: The Lazarus of Contemporary Coronary Intervention

  2023cites this paper
• Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review

  2023cites this paper
• Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents

  2023cites this paper
• Drug-Eluting Stent Restenosis: Modern Approach to a Classic Challenge

  2023cites this paper
• Methods for improving the properties of zinc for the application of biodegradable vascular stents.

  2023cites this paper
• Percutaneous Revascularisation in Diabetic Patients with Coronary Artery Percutaneous Revascularisation in Diabetic Patients with Coronary Artery Disease Disease

  2023cites this paper
• A Synopsis of Stent Graft Technology Development

  2023influential citation
• State-of-art review: intravascular imaging in percutaneous coronary interventions

  2023cites this paper
• Prediction of Major Adverse Cardiovascular Events (MACCE) Following Percutaneous Coronary Intervention Using ANFIS-PSO Model

  2022cites this paper
• Endoprothèses coronaires et angioplastie transluminale des artères coronaires

  2022cites this paper
• Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience

  2022cites this paper
• Revascularization strategies for patients with established chronic coronary syndrome

  2022cites this paper
• Drug-coated Balloons for Small Coronary Disease—A Literature Review

  2021cites this paper
• Modulated molecular markers of restenosis and thrombosis by in-vitro vascular cells exposed to bioresorbable scaffolds

  2021cites this paper
• Implantation of a Coronary Stent Into the Canaliculus of a Human Cadaver: A Pilot Study

  2021cites this paper
• Biomedical Material for Stent Application: Current Status and Future Challenges

  2021cites this paper
• Device profile of the XIENCE V and XIENCE Sierra stents for the treatment of coronary artery disease: an overview of safety and efficacy

  2020cites this paper
• Novel Oral Anticoagulants Following Percutaneous Coronary Intervention

  2020cites this paper
• Adverse events beyond 1 year after percutaneous coronary intervention

  2020cites this paper
• Rassegne Più rischi meno trattamenti : il paradosso degli anziani con sindromi coronariche acute

  2020cites this paper
• Coronaropathie

  2020cites this paper
• University of Birmingham Microstructural and mechanical characterization of thin-walled tube manufactured with selective laser melting for stent application

  2020cites this paper
• Neoatherosclerosis　― Long-Term Assessment of Bioresorbable Vascular Scaffold ―

  2019cites this paper
• Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis

  2019cites this paper
• Patient Specific Coronary Stent Designing and its Computational Analysis using Ansys

  2019cites this paper
• Coronary In-Stent Restenosis: An Algorithmic Approach to Diagnosis and Treatment

  2019cites this paper
• Neue Therapieansätze zur Korrektur der Endothel-funktion nach Ballondilatation S . Schwarzacher

  2019cites this paper
• Antiplatelet therapy for tibial balloon angioplasty: A clinical perspective

  2019cites this paper
• Complex robotic compared to manual coronary interventions: 6‐ and 12‐month outcomes

  2018cites this paper
• Safety and efficacy of second‐generation drug‐eluting stents compared with bare‐metal stents: An updated meta‐analysis and regression of 9 randomized clinical trials

  2018influential citation
• Clinical impact of routine angiographic follow-up after percutaneous coronary interventions on unprotected left main.

  2018cites this paper
• 40 Years of Percutaneous Coronary Intervention: History and Future Directions

  2018influential citation
• Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis.

  2018cites this paper
• Stenting in Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.

  2018cites this paper
• Local adventitial anti-angiogenic gene therapy reduces growth of vasa-vasorum and in-stent restenosis in WHHL rabbits.

  2018cites this paper
• Bioresorbable vascular scaffold: a step back thinking of the future

  2018cites this paper
• Stent thrombosis in patients with drug‑‑eluting stents and bioresorbable vascular scaffolds: the feared complication.

  2018cites this paper
• Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes Without Atrial Fibrillation?

  2018cites this paper
• Two common mutations within CYP2C19 affected platelet aggregation in Chinese patients undergoing PCI: a one-year follow-up study

  2018cites this paper
• TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONAY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) IN SCB MEDICAL COLLEGE, CUTTACK, ODISHA, INDIA.

  2018cites this paper
• Angiography Versus Hemodynamics to Predict the Natural History of Coronary Stenoses: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation 2 Substudy.

  2018cites this paper
• Platelet reactivity in patients with coronary stenting treated with dual antiplatelet therapy and after withdrawal of clopidogrel: Impact of bioactive titanium stent versus everolimus-coated stent

  2018cites this paper
• Associations between endothelial progenitor cells, clinical characteristics and coronary restenosis in patients undergoing percutaneous coronary artery intervention

  2018cites this paper
• Design optimisation for stent manufacture

  2018cites this paper
• Optimal Approach for Treating In-Stent Restenosis

  2018cites this paper
• Breve historia de los stents coronarios

  2018cites this paper
• Drug-eluting stents versus bare-metal stents for acute coronary syndrome.

  2017cites this paper
• The science of stents: angioplasty turns 40

  2017cites this paper
• Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent

  2017cites this paper
• A randomized clinical trial comparing long‐term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug‐eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis‐Extended Antiplatelet Monotherapy (HO

  2017cites this paper
• Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction

  2017cites this paper
• Bioresorbable Vascular Scaffolds　- Are We Facing a Time of Crisis or One of Breakthrough?

  2017cites this paper
• Optimization of dual-wavelength intravascular photoacoustic imaging of atherosclerotic plaques using Monte Carlo optical modeling

  2017cites this paper
• Association of seven renin angiotensin system gene polymorphisms with restenosis in patients following coronary stenting

  2017cites this paper
• Drug‐Coated Balloon Versus Drug‐Eluting Stent in Primary Percutaneous Coronary Intervention: A Feasibility Study☆,☆☆

  2017cites this paper
• State of the art: coronary artery stents - past, present and future.

  2017cites this paper
• A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial.

  2017cites this paper
• Neue Mechanismen zur Verhinderung der myointimalen Hyperplasie

  2017cites this paper
• Anticoagulation Control in Patients With Ventricular Assist Devices

  2017cites this paper
• Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12 inhibitors

  2017cites this paper
• DIRETRIZ DA SOCIEDADE BRASILEIRA DE CARDIOLOGIA E DA SOCIEDADE BRASILEIRA DE HEMODINÂMICA E CARDIOLOGIA INTERVENCIONISTA SOBRE INTERVENÇÃO CORONÁRIA PERCUTÂNEA

  2017cites this paper
• ISCHEMIC HEART DISEASE ( D MUKHERJEE , SECTION EDITOR ) Bioresorbable Scaffolds for Coronary Artery Disease

  2017cites this paper
• New-Generation Coronary Stents: Current Data and Future Directions

  2017cites this paper
• Segmental comparison between a dedicated bifurcation stent and balloon angioplasty using intravascular ultrasound and three‐dimensional quantitative coronary angiography: A subgroup analysis of the Tryton IDE randomized trial

  2017cites this paper
• Costs and Clinical Outcomes in Percutaneous Coronary Intervention by the Brazilian National Health System

  2017cites this paper
• A promising biodegradable magnesium alloy suitable for clinical vascular stent application

  2017cites this paper
• Dual pathway therapy in acute coronary syndrome

  2016cites this paper
• Re-Endothelialization Study on Endovascular Stents Seeded by Endothelial Cells through Up- or Downregulation of VEGF.

  2016cites this paper
• Bioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery Disease.

  2016cites this paper
• MicroRNAs for Restenosis and Thrombosis After Vascular Injury.

  2016cites this paper
• Percutaneous coronary interventions of bifurcation lesions

  2016cites this paper
• Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis.

  2016cites this paper
• Restenosis of the Coronary Arteries: Past, Present, Future Directions.

  2016cites this paper